Follow
Dhanya K. Nambiar
Dhanya K. Nambiar
Instructor, Dept. of Radiation Oncology, Stanford University
Verified email at stanford.edu
Title
Cited by
Cited by
Year
The immune subtypes and landscape of squamous cell carcinoma
B Li, Y Cui, DK Nambiar, JB Sunwoo, R Li
Clinical Cancer Research 25 (12), 3528-3537, 2019
1562019
Usnic acid inhibits growth and induces cell cycle arrest and apoptosis in human lung carcinoma A549 cells
N Singh, D Nambiar, RK Kale, RP Singh
Nutrition and cancer 65 (sup1), 36-43, 2013
1242013
Effects of phytochemicals on ionization radiation-mediated carcinogenesis and cancer therapy
D Nambiar, P Rajamani, RP Singh
Mutation Research/Reviews in Mutation Research 728 (3), 139-157, 2011
1242011
Galectin-1–driven T cell exclusion in the tumor endothelium promotes immunotherapy resistance
DK Nambiar, T Aguilera, H Cao, S Kwok, C Kong, J Bloomstein, Z Wang, ...
The Journal of clinical investigation 129 (12), 5553-5567, 2019
1162019
Hypoxia induces triglycerides accumulation in prostate cancer cells and extracellular vesicles supporting growth and invasiveness following reoxygenation
IR Schlaepfer, DK Nambiar, A Ramteke, R Kumar, D Dhar, C Agarwal, ...
Oncotarget 6 (26), 22836, 2015
1012015
Fisetin inhibits various attributes of angiogenesis in vitro and in vivo —implications for angioprevention
TA Bhat, D Nambiar, A Pal, R Agarwal, RP Singh
Carcinogenesis 33 (2), 385-393, 2012
982012
Chemical space mimicry for drug discovery
W Yuan, D Jiang, DK Nambiar, LP Liew, MP Hay, J Bloomstein, P Lu, ...
Journal of chemical information and modeling 57 (4), 875-882, 2017
902017
Acacetin Inhibits In Vitro and In Vivo Angiogenesis and Downregulates Stat Signaling and VEGF Expression
TA Bhat, D Nambiar, D Tailor, A Pal, R Agarwal, RP Singh
Cancer Prevention Research 6 (10), 1128-1139, 2013
762013
In vitro and in vivo anticancer efficacy of silibinin against human pancreatic cancer BxPC-3 and PANC-1 cells
D Nambiar, V Prajapati, R Agarwal, RP Singh
Cancer letters 334 (1), 109-117, 2013
692013
Silibinin inhibits aberrant lipid metabolism, proliferation and emergence of androgen-independence in prostate cancer cells via primarily targeting the sterol response element …
DK Nambiar, G Deep, RP Singh, C Agarwal, R Agarwal
Oncotarget 5 (20), 10017, 2014
612014
Silibinin inhibits hypoxia‐induced HIF‐1α‐mediated signaling, angiogenesis and lipogenesis in prostate cancer cells: in vitro evidence and in vivo functional imaging and …
G Deep, R Kumar, DK Nambiar, AK Jain, AM Ramteke, NJ Serkova, ...
Molecular carcinogenesis 56 (3), 833-848, 2017
602017
Silibinin attenuates ionizing radiation-induced pro-angiogenic response and EMT in prostate cancer cells
DK Nambiar, P Rajamani, RP Singh
Biochemical and biophysical research communications 456 (1), 262-268, 2015
492015
Silibinin preferentially radiosensitizes prostate cancer by inhibiting DNA repair signaling
DK Nambiar, P Rajamani, G Deep, AK Jain, R Agarwal, RP Singh
Molecular cancer therapeutics 14 (12), 2722-2734, 2015
442015
The prevalence of alcohol and other drugs in fatal road crashes in Victoria, Australia
J Schumann, M Perkins, P Dietze, D Nambiar, B Mitra, D Gerostamoulos, ...
Accident Analysis & Prevention 153, 105905, 2021
322021
Y box binding protein 1 inhibition as a targeted therapy for ovarian cancer
D Tailor, A Resendez, FJ Garcia-Marques, M Pandrala, CC Going, ...
Cell Chemical Biology 28 (8), 1206-1220. e6, 2021
302021
Aldehyde dehydrogenase 3A1 activation prevents radiation-induced xerostomia by protecting salivary stem cells from toxic aldehydes
JP Saiki, H Cao, LD Van Wassenhove, V Viswanathan, J Bloomstein, ...
Proceedings of the National Academy of Sciences 115 (24), 6279-6284, 2018
252018
Advances in prostate cancer chemoprevention: a translational perspective
D Nambiar, RP Singh
Nutrition and cancer 65 (sup1), 12-25, 2013
252013
NFE2L2 Mutations Enhance Radioresistance in Head and Neck Cancer by Modulating Intratumoral Myeloid Cells
L Guan, DK Nambiar, H Cao, V Viswanathan, S Kwok, AB Hui, Y Hou, ...
Cancer research 83 (6), 861-874, 2023
182023
Novel Aza-podophyllotoxin derivative induces oxidative phosphorylation and cell death via AMPK activation in triple-negative breast cancer
D Tailor, CC Going, A Resendez, V Kumar, DK Nambiar, Y Li, A Dheeraj, ...
British Journal of Cancer 124 (3), 604-615, 2021
162021
Targeting DNA repair for cancer treatment: Lessons from PARP inhibitor trials
DK Nambiar, D Mishra, RP Singh
Oncology research 31 (4), 405, 2023
102023
The system can't perform the operation now. Try again later.
Articles 1–20